Diamyd Medical offers instant and continuous delivery of
highly purified (>99%) GAD65, which can be used for
mechanistic studies and therapy development in preclinical research. When your application is approved for testing in clinical trials, Diamyd Medical can supply investigational GMP GAD65 fomulated in alum according to applicable regulations.
Full-length recombinant human GAD65 is supplied in 2 forms for scientific preclinical research use only. Final product for preclinical research is requalified by SDS-PAGE, Western blot, IEF and biological activity.
The UniProt Consortium provides protein sequence and functional information on human GAD65 (Glutamate Decarboxylase2).
UniProtKB - Q05329 (DCE2HUMAN)
References to scientific publications on clinical research where rhGAD65 or T-cell GAD provided by Diamyd Medical is used.
rhGAD65 and T-cell GAD is offered to academia and industry for preclinical research purposes only and may not be used in humans.